基于深度神经网络的无需MRI的快速准确脑淀粉样蛋白PET定量
研究提出一种基于深度学习空间归一化的淀粉样蛋白PET自动定量方法,无需同一患者的MRI或CT。用994例多中心淀粉样蛋白PET图像训练神经网络,并在148例及外部独立数据集上验证,与FreeSurfer的MRI分割定量比较。所提方法与FreeSurfer估计的相关性强于基于SPM的MRI空间归一化,在多数脑区线性回归参数和组内相关系数更优。
要点
- 深度学习空间归一化无需结构MRI即可定量淀粉样蛋白脑PET。
- 所提方法与FreeSurfer估计的相关性强于SPM空间归一化。
- 外部验证中无需MRI的所提方法性能优于使用MRI的SPM。
核心结论
- 所提深度学习空间归一化方法无需结构MRI即可对淀粉样蛋白脑PET图像进行定量分析。
- 所提方法的定量结果与基于FreeSurfer的MRI分割定量在所有临床淀粉样蛋白示踪剂中均显示强相关。
- 作者认为所提方法将有助于利用淀粉样蛋白PET扫描研究阿尔茨海默病及相关脑部疾病。
研究设计与样本
- 深度学习空间归一化模型使用994例多中心淀粉样蛋白PET图像(367例18F-flutemetamol和627例18F-florbetaben)及对应三维MR图像训练,受试者包括阿尔茨海默病、轻度认知障碍或认知正常者。
- 准确性评估使用另外148例淀粉样蛋白PET图像(64例18F-flutemetamol和84例18F-florbetaben),与基于FreeSurfer的个体脑空间MRI分割PET定量比较。
- 外部验证使用未见独立外部数据集(30例18F-flutemetamol、67例18F-florbetaben和39例18F-florbetapir)。
- 比较对象包括基于SPM(Statistical Parametric Mapping程序第12版)的PET空间归一化。
主要发现
- 所提深度学习方法定量结果与FreeSurfer估计的相关性强于使用MRI的SPM空间归一化。
- 全脑皮层SPM与FreeSurfer之间的斜率、y截距和R²分别为0.869、0.113和0.946。
- 全脑皮层所提深度学习方法与FreeSurfer之间的斜率、y截距和R²分别为1.019、-0.016和0.986。
- 外部验证研究也显示无需MR图像的所提方法性能优于使用MRI的SPM。
- 在多数脑区,所提方法在线性回归参数和组内相关系数方面优于SPM空间归一化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This paper proposes a novel method for automatic quantification of amyloid PET using deep learning-based spatial normalization (SN) of PET images, which does not require MRI or CT images of the same patient. The accuracy of the method was evaluated for 3 different amyloid PET radiotracers compared with MRI-parcellation-based PET quantification using FreeSurfer. Methods: A deep neural network model used for the SN of amyloid PET images was trained using 994 multicenter amyloid PET images (367 18F-flutemetamol and 627 18F-florbetaben) and the corresponding 3-dimensional MR images of subjects who had Alzheimer disease or mild cognitive impairment or were cognitively normal. For comparison, PET SN was also conducted using version 12 of the Statistical Parametric Mapping program (SPM-based SN). The accuracy of deep learning-based and SPM-based SN and SUV ratio quantification relative to the FreeSurfer-based estimation in individual brain spaces was evaluated using 148 other amyloid PET images (64 18F-flutemetamol and 84 18F-florbetaben). Additional external validation was performed using an unseen independent external dataset (30 18F-flutemetamol, 67 18F-florbetaben, and 39 18F-florbetapir). Results: Quantification results using the proposed deep learning-based method showed stronger correlations with the FreeSurfer estimates than SPM-based SN using MRI did. For example, the slope, y-intercept, and R 2 values between SPM and FreeSurfer for the global cortex were 0.869, 0.113, and 0.946, respectively. In contrast, the slope, y-intercept, and R 2 values between the proposed deep learning-based method and FreeSurfer were 1.019, -0.016, and 0.986, respectively. The external validation study also demonstrated better performance for the proposed method without MR images than for SPM with MRI. In most brain regions, the proposed method outperformed SPM SN in terms of linear regression parameters and intraclass correlation coefficients. Conclusion: We evaluated a novel deep learning-based SN method that allows quantitative analysis of amyloid brain PET images without structural MRI. The quantification results using the proposed method showed a strong correlation with MRI-parcellation-based quantification using FreeSurfer for all clinical amyloid radiotracers. Therefore, the proposed method will be useful for investigating Alzheimer disease and related brain disorders using amyloid PET scans.
引用
- Kang SK, Kim D, Shin SA, et al. Fast and Accurate Amyloid Brain PET Quantification Without MRI Using Deep Neural Networks. J Nucl Med. 2022. PMID: 36328490. doi:10.2967/jnumed.122.264414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。